Pharma And Biotech Q2, In Brief
Lilly Not Ruling Out Pfizer Animal Health
You may also be interested in...
Pfizer takes a middle-of-the-road approach to breaking out non-core businesses, announcing plans to explore alternatives for Animal Health and Nutrition.
Pfizer tells analysts the deal will have an incremental not "instrumental" impact on its established products and emerging markets strategy.
CHF Solutions adds “CEO” to its president’s job title; Agilent VP of business development promoted to senior VP; Zimmer hires chief transformation officer; and more.